Anlon Healthcare Ltd vs Indo Borax Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 29, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 116 as of 27 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Indo Borax & Chemicals Ltd changed from 6.1 on March 2021 to 13.3 on March 2024 . This represents a CAGR of 21.52% over 4 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Indo Borax & Chemicals Ltd changed from ₹ 210.09 crore on March 2021 to ₹ 545.05 crore on March 2025 . This represents a CAGR of 21.01% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Indo Borax & Chemicals Ltd for the Dec '25 is ₹ 45.35 crore as compare to the Sep '25 revenue of ₹ 70.77 crore. This represent the decline of -35.92% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Indo Borax & Chemicals Ltd for the Dec '25 is ₹ 12.95 crore as compare to the Sep '25 ebitda of ₹ 23.42 crore. This represent the decline of -44.71% The net profit of Anlon Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Indo Borax & Chemicals Ltd changed from ₹ 14.01 crore to ₹ 9.27 crore over 7 quarters. This represents a CAGR of -21.02% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Indo Borax & Chemicals Ltd changed from 9.24 % on March 2021 to 7.66 % on March 2025 . This represents a CAGR of -3.68% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About Indo Borax & Chemicals Ltd

Indo Borax and Chemicals Limited (IBCL) is into the business of manufacturing and selling of Boron and Lithium products which includes Boric Acid Technical Grade Powder & Granular, Boric Acid IP Grade (Indian Pharmacopoeia Grade) Powder & Granular, and Lithium Hydroxide Monohydrate. The Company's plant is located in Pithampur, Madhya Pradesh.
Its BORIC ACID (Tech.
Grade) Powder is used for fluxes and metallurgical operation, such as welding, paste fluxes and soldering fluxes.
The Company's subsidiary is Indoborax Infrastructure Pvt.
Ltd (IIPL). Indo Borax came into existence in 1980 and the company established its first Boric Acid plant at Asangaon in Maharashtra in the year 1981, followed by the establishment of a Borax plant in 1983.

FAQs for the comparison of Anlon Healthcare Ltd and Indo Borax & Chemicals Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or Indo Borax & Chemicals Ltd?

Market cap of Anlon Healthcare Ltd is 616 Cr while Market cap of Indo Borax & Chemicals Ltd is 780 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and Indo Borax & Chemicals Ltd?

The stock performance of Anlon Healthcare Ltd and Indo Borax & Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and Indo Borax & Chemicals Ltd?

As of March 29, 2026, the Anlon Healthcare Ltd stock price is INR ₹116.0. On the other hand, Indo Borax & Chemicals Ltd stock price is INR ₹243.3.

How do dividend payouts of Anlon Healthcare Ltd and Indo Borax & Chemicals Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and Indo Borax & Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.